Physician profile
Beth V Barlet
NPI 1568799476
$2,959.00
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,206 · 2022: $1,247 · 2023: $506.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $412 · Education: $94.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $412.12 |
| Education | $94.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $606.16 | 2021-2023 | Dupixent |
| Abbvie INC. | $566.00 | 2021-2023 | |
| Sun Pharmaceutical Industries INC. | $364.33 | 2021-2023 | Ilumya |
| Janssen Biotech, INC. | $276.60 | 2021-2023 | Tremfya |
| Novartis Pharmaceuticals Corporation | $170.65 | 2021-2023 | |
| Lilly USA, LLC | $158.33 | 2021-2023 | Olumiant, Taltz |
| Ucb, INC. | $153.24 | 2021-2023 | Cimzia |
| Genzyme Corporation | $138.33 | 2021-2022 | |
| Incyte Corporation | $119.66 | 2022-2023 | Opzelura |
| Pfizer INC. | $65.32 | 2021-2022 | |
| Leo Pharma INC. | $64.49 | 2021-2023 | Adbry |
| E.R. Squibb & Sons, L.L.C. | $62.25 | 2023 | Sotyktu |
| Amgen INC. | $57.87 | 2021-2023 | Enbrel, Otezla |
| Almirall LLC | $52.04 | 2021-2023 | Klisyri |
| Genentech USA, INC. | $34.83 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dermavant Sciences, INC. | $31.68 | 2022-2023 | Vtama |
| Mayne Pharma Commercial LLC | $20.18 | 2021 | |
| Organogenesis INC. | $17.04 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Beth Barlet listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.